Skip to main content

Table 1 Case-study: APOSTEL VI

From: A qualitative study on acceptable levels of risk for pregnant women in clinical research

The APOSTEL studies are a series of studies in the field of treatment of preterm labour within the Dutch Consortium for Healthcare Evaluation and Research in Obstetrics and Gynecology (NVOG Consortium 2.0.). The APOSTEL VI study in particular assesses whether a cervical pessary prolongs pregnancy in women who have been admitted for threatened preterm birth but remained undelivered after 48 h ( Women are randomly allocated to receive either a cervical pessary or no intervention. Women participating in the study were not perceived to be at an increased risk since previous studies using the pessary had shown no foetal adverse effects and the cervical pessary was not associated with increased neonatal or maternal morbidity and mortality (APOSTEL VI Research Protocol).
The APOSTEL VI study took place from November 2013 until September 2016, when the study was prematurely stopped following the advice of the Data and Safety Monitoring Board (DSMB). The premature cancellation was due to the fact that after interim analysis the intervention was unlikely to improve outcome, and maternal side effects were often present in the intervention arm.
Our qualitative study took place from March 2015 till September 2016 and we reached saturation before the APOSTEL VI itself was cancelled. In all our interviews it was therefore assumed that the APOSTEL VI would be completed.